Cdk5 phosphorylation of EFhd2 at S74 affects its calcium binding activity

Protein Science

Volumn 23, Issue 9, 2014, Pages 1197-1207

  Vázquez Rosa, Edwin ^a,b   Rodríguez Cruz, Eva N ^a,b   Serrano, Sybelle ^a   Rodríguez Laureano, Lucelenie ^a   Vega, Irving E ^a,b  

^a UNIVERSITY OF PUERTO RICO RIO PIEDRAS   (Puerto Rico)

^b UNIVERSITY OF PUERTO RICO   (Puerto Rico)

Author keywords

Calcium binding; Cdk5; EFhd2; Phosphorylation; Tau; Tauopathy

Indexed keywords

CALCIUM; CALCIUM BINDING PROTEIN; CDK5 PROTEIN, HUMAN; CDK5 PROTEIN, MOUSE; CYCLIN DEPENDENT KINASE 5; EFHD2 PROTEIN, HUMAN;

ANIMAL; BINDING SITE; CHEMISTRY; GENETICS; HUMAN; METABOLISM; MOUSE; MUTATION; PHOSPHORYLATION; TRANSGENIC MOUSE;

ANIMALS; BINDING SITES; CALCIUM; CALCIUM-BINDING PROTEINS; CYCLIN-DEPENDENT KINASE 5; HUMANS; MICE; MICE, TRANSGENIC; MUTATION; PHOSPHORYLATION;

EID: 84906888245     PISSN: 09618368     EISSN: 1469896X     Source Type: Journal    
DOI: 10.1002/pro.2499     Document Type: Article

References (34)

1. Vuadens F, Rufer N, Kress A, Corthesy P, Schneider P, Tissot JD (2004) Identification of swiprosin 1 in human lymphocytes. Proteomics 4:2216-2220.
2. Avramidou A, Kroczek C, Lang C, Schuh W, Jack HM, Mielenz D (2007) The novel adaptor protein Swiprosin- 1 enhances BCR signals and contributes to BCRinduced apoptosis. Cell Death Differ 14:1936-1947.
3. Vega IE, Traverso EE, Ferrer-Acosta Y, Matos E, Colon M, Gonzalez J, Dickson D, Hutton M, Lewis J, Yen SH (2008) A novel calcium-binding protein is associated with tau proteins in tauopathy. J Neurochem 106:96- 106.
4. Dutting S, Brachs S, Mielenz D (2011) Fraternal twins: swiprosin-1/EFhd2 and Swiprosin-2/EFhd1, two homologous EF-hand containing calcium binding adaptor proteins with distinct functions. Cell Commun Signal 9:2.
5. Kroczek C, Lang C, Brachs S, Grohmann M, Dutting S, Schweizer A, Nitschke L, Feller SM, Jack HM, Mielenz D (2010) Swiprosin-1/EFhd2 controls B cell receptor signaling through the assembly of the B cell receptor, Syk, and phospholipase C gamma2 in membrane rafts. J Immunol 184:3665-3676.
6. Hagen S, Brachs S, Kroczek C, Furnrohr BG, Lang C, Mielenz D (2012) The B cell receptor-induced calcium flux involves a calcium mediated positive feedback loop. Cell Calcium 51:411-417.
7. Huh YH, Kim SH, Chung KH, Oh S, Kwon MS, Choi HW, Rhee S, Ryu JH, Park ZY, Jun CD, Song WK (2013) Swiprosin-1 modulates actin dynamics by regulating the F-actin accessibility to cofilin. Cell Mol Life Sci. 70:4841-4854.
8. Kwon MS, Park KR, Kim YD, Na BR, Kim HR, Choi HJ, Piragyte I, Jeon H, Chung KH, Song WK, Eom SH, Jun CD (2013) Swiprosin-1 is a novel actin bundling protein that regulates cell spreading and migration. PLoS One 8:e71626.
9. Blethrow JD, Glavy JS, Morgan DO, Shokat KM (2008) Covalent capture of kinase-specific phosphopeptides reveals Cdk1-cyclin B substrates. Proc Natl Acad Sci USA 105:1442-1447.
10. Zanivan S, Gnad F, Wickstrom SA, Geiger T, Macek B, Cox J, Fassler R, Mann M (2008) Solid tumor proteome and phosphoproteome analysis by high resolution mass spectrometry. J Proteome Res 7:5314-5326.
11. Dephoure N, Zhou C, Villen J, Beausoleil SA, Bakalarski CE, Elledge SJ, Gygi SP (2008) A quantitative atlas of mitotic phosphorylation. Proc Natl Acad Sci USA 105:10762-10767.
12. Ballif BA, Carey GR, Sunyaev SR, Gygi SP (2008) Large-scale identification and evolution indexing of tyrosine phosphorylation sites from murine brain. J Proteome Res 7:311-318.
13. Weintz G, Olsen JV, Fruhauf K, Niedzielska M, Amit I, Jantsch J, Mages J, Frech C, Dolken L, Mann M, et al. (2010) The phosphoproteome of toll-like receptor-activated macrophages. Mol Syst Biol 6:371.
14. Wisniewski JR, Nagaraj N, Zougman A, Gnad F, Mann M (2010) Brain phosphoproteome obtained by a FASPbased method reveals plasma membrane protein topology. J Proteome Res 9:3280-3289.
15. Huttlin EL, Jedrychowski MP, Elias JE, Goswami T, Rad R, Beausoleil SA, Villen J, Haas W, Sowa ME, Gygi SP (2010) A tissue-specific atlas of mouse protein phosphorylation and expression. Cell 143:1174-1189.
16. Olsen JV, Vermeulen M, Santamaria A, Kumar C, Miller ML, Jensen LJ, Gnad F, Cox J, Jensen TS, Nigg EA, et al. (2010) Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis. Sci Signal 3:ra3.
17. Nagano K, Shinkawa T, Mutoh H, Kondoh O, Morimoto S, Inomata N, Ashihara M, Ishii N, Aoki Y, Haramura M (2009) Phosphoproteomic analysis of distinct tumor cell lines in response to nocodazole treatment. Proteomics 9:2861-2874.
18. Ferrer-Acosta Y, Rodriguez-Cruz EN, Orange F, De Jesus-Cortes H, Madera B, Vaquer-Alicea J, Ballester J, Guinel MJ, Bloom GS, Vega IE (2013) EFhd2 is a novel amyloid protein associated with pathological tau in Alzheimer's disease. J Neurochem 125:921-931.
19. Noble W, Olm V, Takata K, Casey E, Mary O, Meyerson J, Gaynor K, LaFrancois J, Wang L, Kondo T, et al. (2003) Cdk5 is a key factor in tau aggregation and tangle formation in vivo. Neuron 38:555-565.
20. Patrick GN, Zukerberg L, Nikolic M, de la Monte S, Dikkes P, Tsai LH (1999) Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature 402:615-622.
21. Noble W, Planel E, Zehr C, Olm V, Meyerson J, Suleman F, Gaynor K, Wang L, LaFrancois J, Feinstein B, et al. (2005) Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo. Proc Natl Acad Sci USA 102:6990-6995.
22. Plattner F, Angelo M, Giese KP (2006) The roles of cyclin-dependent kinase 5 and glycogen synthase kinase 3 in tau hyperphosphorylation. J Biol Chem 281:25457-25465.
23. Tsai LH, Delalle I, Caviness VS Jr, Chae T, Harlow E (1994) p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5. Nature 371:419-423.
24. Lee KY, Clark AW, Rosales JL, Chapman K, Fung T, Johnston RN (1999) Elevated neuronal Cdc2-like kinase activity in the Alzheimer disease brain. Neurosci Res 34:21-29.
25. Hashiguchi M, Saito T, Hisanaga S, Hashiguchi T (2002) Truncation of CDK5 activator p35 induces intensive phosphorylation of Ser202/Thr205 of human tau. J Biol Chem 277:44525-44530.
26. Lew J, Huang QQ, Qi Z, Winkfein RJ, Aebersold R, Hunt T, Wang JH (1994) A brain-specific activator of cyclin-dependent kinase 5. Nature 371:423-426.
27. Kusakawa G, Saito T, Onuki R, Ishiguro K, Kishimoto T, Hisanaga S (2000) Calpain-dependent proteolytic cleavage of the p35 cyclin-dependent kinase 5 activator to p25. J Biol Chem 275:17166-17172.
28. Lee MS, Kwon YT, Li M, Peng J, Friedlander RM, Tsai LH (2000) Neurotoxicity induces cleavage of p35 to p25 by calpain. Nature 405:360-364.
29. Nath R, Davis M, Probert AW, Kupina NC, Ren X, Schielke GP, Wang KK (2000) Processing of cdk5 activator p35 to its truncated form (p25) by calpain in acutely injured neuronal cells. Biochem Biophys Res Commun 274:16-21.
30. Cruz JC, Tseng HC, Goldman JA, Shih H, Tsai LH (2003) Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles. Neuron 40:471-483.
31. Meijer L, Borgne A, Mulner O, Chong JP, Blow JJ, Inagaki N, Inagaki M, Delcros JG, Moulinoux JP (1997) Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5. Eur J Biochem 243:527- 536.
32. Price DA, Sorkin A, Zahniser NR (2009) Cyclin-dependent kinase 5 inhibitors: inhibition of dopamine transporter activity. Mol Pharmacol 76:812-823.
33. Peterson DW, Ando DM, Taketa DA, Zhou H, Dahlquist FW, Lew J (2010) No difference in kinetics of tau or histone phosphorylation by CDK5/p25 versus CDK5/p35 in vitro. Proc Natl Acad Sci USA 107:2884- 2889.
34. Ferrer-Acosta Y, Rodriguez Cruz EN, Vaquer Adel C, Vega IE (2013) Functional and structural analysis of the conserved EFhd2 protein. Protein Pept Lett 20: 573-583.